Back to Agenda
Session 2 - Asia’s Potential as a Hub for Global Clinical Trials
Session Chair(s)
Audrey Ooi, MSc
Head- Business Development
Clinical Research Malaysia, Malaysia
Martin Lim, MBA, MS
Co-Founder and CEO
ONWARD Health Research, Singapore
Asia is increasingly being seen as an integral player and contributor of global clinical trial success. With the fast-growing pharmaceutical and medical device market, there has been many growing interests to shift the globalization of clinical development to Asia, due to the value propositions it has to offer, including a vast and treatment-naive patient pool, high-quality infrastructure, and availability of a skilled clinical workforce. This session aims to share the best practices and supportive structures in place that can further accelerate Asia as a clinical trial powerhouse.
Speaker(s)
Enabling Multi-National Research through Collaborative Networks in Asia
Maria Ruriko Umano-Urbiztondo
Sciences, National Center For Global Health and Medicine, Japan
Regional manager, Department of International Trials (DIT), Center for Clinical
Asia’s Attractiveness as a Clinical Trial Hub: Of Supportive Policies and Ecosystems
John Ang
Tigermed, Malaysia
Head of Project Management Office, Senior Director
Health Systems and Infrastructure Readiness in Asia
Milind Sabnis
Frost & Sullivan, Singapore
Head of Consulting, Healthcare & Life Sciences APAC
Have an account?